Related references
Note: Only part of the references are listed.The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Richard Cunningham et al.
CLINICAL SCIENCE (2022)
Identification of Small-molecule YAP-TEAD inhibitors by High-throughput docking for the Treatment of colorectal cancer
Lijun Li et al.
BIOORGANIC CHEMISTRY (2022)
Hippo Signaling in Embryogenesis and Development
Zhengming Wu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
YAP and TAZ Are Not Identical Twins
Francesca Reggiani et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
Editor's Note: Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein (vol 69, pg 1089, 2009)
Bin Zhao et al.
CANCER RESEARCH (2021)
Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma
Tracy T. Tang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3
Tian Lu et al.
ACTA PHARMACEUTICA SINICA B (2021)
The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1)
Songlin He et al.
BIOENGINEERED (2021)
The metabolism of cancer cells during metastasis
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2021)
YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression
Tianyu Shen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Lats1/2 Sustain Intestinal Stem Cells and Wnt Activation through TEAD-Dependent and Independent Transcription
Qi Li et al.
CELL STEM CELL (2020)
Reduction of protein phosphatase 2A (PP2A) complexity reveals cellular functions and dephosphorylation motifs of the PP2A/B?? holoenzyme
Chian Ju Jong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Anwesha Dey et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling
Jeffrey K. Holden et al.
CELL REPORTS (2020)
Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket
Hacer Karatas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A new perspective on the interaction between the Vg/VGLL1-3 proteins and the TEAD transcription factors
Yannick Mesrouze et al.
SCIENTIFIC REPORTS (2020)
Protein-Protein Interaction Disruptors of the YAP/TAZ-TEAD Transcriptional Complex
Ajaybabu V. Pobbati et al.
MOLECULES (2020)
YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN
Liwen Guo et al.
FEBS OPEN BIO (2019)
Analysis of the role of the Hippo pathway in cancer
Yanyan Han
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The Hippo Signaling Pathway in Development and Disease
Yonggang Zheng et al.
DEVELOPMENTAL CELL (2019)
Identification of Quinolinols as Activators of TEAD-Dependent Transcription
Ajaybabu V. Pobbati et al.
ACS CHEMICAL BIOLOGY (2019)
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer
Mi Ran Yun et al.
EMBO MOLECULAR MEDICINE (2019)
Discovery and biological evaluation of vinylsulfonamide derivatives as highly potent, covalent TEAD autopalmitoylation inhibitors
Wenchao Lu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
Sarah A. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of a first-in-class TEAD inhibitor which directly inhibits YAP/TAZ-TEAD protein-protein interaction and shows a potent anti-tumor effect in malignant pleural mesothelioma
Ayumi Kaneda et al.
CANCER RESEARCH (2019)
Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD•Yap Protein-Protein Interaction
Khuchtumur Bum-Erdene et al.
CELL CHEMICAL BIOLOGY (2019)
A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Shumei Song et al.
MOLECULAR CANCER THERAPEUTICS (2018)
A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
Michael Carducci et al.
INVESTIGATIONAL NEW DRUGS (2018)
Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
Jeffrey K. Holden et al.
CANCERS (2018)
The Epithelial-to-Mesenchymal Transition in Cancer
Joelle Roche
CANCERS (2018)
Yap regulates glucose utilization and sustains nucleotide synthesis to enable organ growth
Andrew G. Cox et al.
EMBO JOURNAL (2018)
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
A. Noto et al.
ONCOGENE (2017)
Regulation of the Hippo Pathway Transcription Factor TEAD
Kimberly C. Lin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
Hung Yi Kristal Kaan et al.
SCIENTIFIC REPORTS (2017)
A Potential Structural Switch for Regulating DNA-Binding by TEAD Transcription Factors
Dong-Sun Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
Fuqin Fan et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Expression and significance of Hippo/YAP signaling in glioma progression
Hao Zhang et al.
TUMOR BIOLOGY (2016)
Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
Fa-Xing Yu et al.
CELL (2015)
Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer
Juan Diaz-Martin et al.
ENDOCRINE-RELATED CANCER (2015)
YAP/TAZ for cancer therapy: Opportunities and challenges
Liwen Guo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy
Ajaybabu V. Pobbati et al.
STRUCTURE (2015)
MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway
Zhipeng Meng et al.
NATURE COMMUNICATIONS (2015)
MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells
Cristian Taccioli et al.
ONCOTARGET (2015)
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling
Anja Heinemann et al.
ONCOTARGET (2015)
Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
Wenqi Wang et al.
CELL REPORTS (2015)
Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
Yusuke Oku et al.
FEBS OPEN BIO (2015)
The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
Katarzyna Brodowska et al.
EXPERIMENTAL EYE RESEARCH (2014)
YAP activation is an early event and a potential therapeutic target in liver cancer development
Andrea Perra et al.
JOURNAL OF HEPATOLOGY (2014)
Identification, Mechanism of Action, and Antitumor Activity of a Small Molecule Inhibitor of Hippo, TGF-β, and Wnt Signaling Pathways
Dipanjan Basu et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction
Zhisen Zhang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
Jian-Ye Liu et al.
BMC CANCER (2013)
Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2
Feng Yin et al.
CELL (2013)
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
Fernando Calvo et al.
NATURE CELL BIOLOGY (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes
T. Mizuno et al.
ONCOGENE (2012)
Py2T Murine Breast Cancer Cells, a Versatile Model of TGFβ-Induced EMT In Vitro and In Vivo
Lorenz Waldmeier et al.
PLOS ONE (2012)
Structures of YAP protein domains reveal promising targets for development of new cancer drugs
Marius Sudol et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Structural and Functional Similarity between the Vgll1-TEAD and the YAP-TEAD Complexes
Ajaybabu V. Pobbati et al.
STRUCTURE (2012)
Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
Munir R. Tanas et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Structural basis of YAP recognition by TEAD4 in the Hippo pathway
Liming Chen et al.
GENES & DEVELOPMENT (2010)
Structural insights into the YAP and TEAD complex
Ze Li et al.
GENES & DEVELOPMENT (2010)
YAP1 and VGLL3, Encoding Two Cofactors of TEAD Transcription Factors, Are Amplified and Overexpressed in a Subset of Soft Tissue Sarcomas
Zofia Helias-Rodzewicz et al.
GENES CHROMOSOMES & CANCER (2010)
The Hippo Signaling Pathway Components Lats and Yap Pattern Tead4 Activity to Distinguish Mouse Trophectoderm from Inner Cell Mass
Noriyuki Nishioka et al.
DEVELOPMENTAL CELL (2009)
Discovery of Small Molecule Inhibitors of Protein-Protein Interactions Using Combined Ligand and Target Score Normalization
Fergal P. Casey et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Tead4 is required for specification of trophectoderm in pre-implantation mouse embryos
Noriyuki Nishioka et al.
MECHANISMS OF DEVELOPMENT (2008)
Elucidation of a universal size-control mechanism in Drosophila and mammals
Jixin Dong et al.
CELL (2007)
Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila
Xiaomu Wei et al.
EMBO JOURNAL (2007)
The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP
JB Huang et al.
CELL (2005)
Transcription cofactor Vgl-2 is required for skeletal muscle differentiation
HH Chen et al.
GENESIS (2004)
Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates α1-adrenergic activation of gene expression in cardiac myocytes
HH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Share Paper
